company background image
603222 logo

Chimin Health Management SHSE:603222 Stock Report

Last Price

CN¥5.71

Market Cap

CN¥3.0b

7D

0.9%

1Y

-49.3%

Updated

24 Apr, 2024

Data

Company Financials

Chimin Health Management Co., Ltd.

SHSE:603222 Stock Report

Market Cap: CN¥3.0b

603222 Stock Overview

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally.

603222 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 603222 from our risk checks.

Chimin Health Management Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chimin Health Management
Historical stock prices
Current Share PriceCN¥5.71
52 Week HighCN¥13.02
52 Week LowCN¥4.70
Beta-0.056
1 Month Change-11.61%
3 Month Change-18.89%
1 Year Change-49.33%
3 Year Change-50.65%
5 Year Change-73.04%
Change since IPO50.83%

Recent News & Updates

Recent updates

Shareholder Returns

603222CN PharmaceuticalsCN Market
7D0.9%3.0%1.6%
1Y-49.3%-12.9%-15.1%

Return vs Industry: 603222 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.

Return vs Market: 603222 underperformed the CN Market which returned -15.1% over the past year.

Price Volatility

Is 603222's price volatile compared to industry and market?
603222 volatility
603222 Average Weekly Movement7.9%
Pharmaceuticals Industry Average Movement7.7%
Market Average Movement8.8%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 603222's share price has been volatile over the past 3 months.

Volatility Over Time: 603222's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19961,851Yunfei Tianwww.chimin.cn

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products.

Chimin Health Management Co., Ltd. Fundamentals Summary

How do Chimin Health Management's earnings and revenue compare to its market cap?
603222 fundamental statistics
Market capCN¥3.02b
Earnings (TTM)-CN¥2.11m
Revenue (TTM)CN¥875.01m

3.5x

P/S Ratio

-1,437x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603222 income statement (TTM)
RevenueCN¥875.01m
Cost of RevenueCN¥493.90m
Gross ProfitCN¥381.11m
Other ExpensesCN¥383.22m
Earnings-CN¥2.11m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)-0.004
Gross Margin43.56%
Net Profit Margin-0.24%
Debt/Equity Ratio26.1%

How did 603222 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-526%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.